1,1-dichloroethene decreases expression ISO RGD:1615020 6480464 vinylidene chloride results in decreased expression of MFSD2A mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1615020 6480464 1, 2-Dimethylhydrazine results in increased expression of MFSD2A mRNA CTD PMID:22206623 15-acetyldeoxynivalenol increases expression ISO RGD:1606200 6480464 15-acetyldeoxynivalenol results in increased expression of MFSD2A mRNA CTD PMID:23792671 17beta-estradiol decreases expression ISO RGD:1606200 6480464 Estradiol results in decreased expression of MFSD2A mRNA CTD PMID:20106945 17beta-estradiol increases expression ISO RGD:1606200 6480464 Estradiol results in increased expression of MFSD2A mRNA CTD PMID:31614463 17beta-estradiol increases expression ISO RGD:1615020 6480464 Estradiol results in increased expression of MFSD2 mRNA CTD PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1606200 6480464 Dihydrotestosterone results in increased expression of MFSD2A mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1615020 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1606200 6480464 Tetrachlorodibenzodioxin results in decreased expression of MFSD2 mRNA, Tetrachlorodibenzodioxin results in decreased expression of MFSD2A mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MFSD2A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1615020 6480464 Tetrachlorodibenzodioxin results in increased expression of MFSD2A mRNA CTD PMID:19465110 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1615020 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:25975270 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MFSD2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615020 6480464 Tetrachlorodibenzodioxin affects the expression of MFSD2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1615020 6480464 Tetrachlorodibenzodioxin results in decreased expression of MFSD2 mRNA, Tetrachlorodibenzodioxin results in decreased expression of MFSD2A mRNA CTD PMID:15034205 , PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MFSD2A mRNA CTD PMID:21215274 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 , PMID:32109520 2-hydroxypropanoic acid increases expression ISO RGD:1606200 6480464 Lactic Acid results in increased expression of MFSD2A mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1615020 6480464 3 more ... CTD PMID:19467301 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1615020 6480464 Triiodothyronine results in increased expression of MFSD2A mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1615020 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MFSD2A mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of MFSD2A mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol decreases expression ISO RGD:1615020 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of MFSD2A mRNA CTD PMID:30951980 , PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1615020 6480464 Fenretinide results in increased expression of MFSD2A mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MFSD2A mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1606200 6480464 Aflatoxin B1 affects the expression of MFSD2A protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1606200 6480464 Aflatoxin B1 results in decreased methylation of MFSD2A intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1606200 6480464 Aflatoxin B1 results in decreased expression of MFSD2A mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1615020 6480464 Aflatoxin B1 results in decreased expression of MFSD2 mRNA CTD PMID:19770486 antirheumatic drug decreases expression ISO RGD:1606200 6480464 Antirheumatic Agents results in decreased expression of MFSD2A mRNA CTD PMID:24449571 arsane decreases expression ISO RGD:1615020 6480464 Arsenic results in decreased expression of MFSD2A mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:1615020 6480464 Arsenic results in decreased expression of MFSD2A mRNA CTD PMID:19654921 benzo[a]pyrene decreases expression ISO RGD:1606200 6480464 Benzo(a)pyrene results in decreased expression of MFSD2A mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1606200 6480464 Benzo(a)pyrene results in increased methylation of MFSD2A promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1606200 6480464 Benzo(a)pyrene results in decreased methylation of MFSD2A 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1606200 6480464 Benzo(a)pyrene results in increased expression of MFSD2A mRNA CTD PMID:24361490 benzo[a]pyrene multiple interactions ISO RGD:1615020 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of MFSD2A mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression ISO RGD:1615020 6480464 Benzo(a)pyrene results in increased expression of MFSD2A mRNA CTD PMID:15034205 benzo[a]pyrene decreases expression ISO RGD:1615020 6480464 Benzo(a)pyrene results in decreased expression of MFSD2 mRNA, Benzo(a)pyrene results in decreased expression of MFSD2A mRNA CTD PMID:19770486 , PMID:21715664 benzo[b]fluoranthene decreases expression ISO RGD:1615020 6480464 benzo(b)fluoranthene results in decreased expression of MFSD2A mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:1615020 6480464 benzo(k)fluoranthene results in increased expression of MFSD2A mRNA CTD PMID:26377693 beta-naphthoflavone decreases expression ISO RGD:1606200 6480464 beta-Naphthoflavone results in decreased expression of MFSD2A mRNA CTD PMID:32858204 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of MFSD2A mRNA CTD PMID:17630414 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1615020 6480464 Diethylhexyl Phthalate results in decreased expression of MFSD2 mRNA, Diethylhexyl Phthalate results in decreased expression of MFSD2A mRNA CTD PMID:19850644 , PMID:28085963 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1615020 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 , PMID:28433925 bisphenol A decreases expression ISO RGD:1615020 6480464 bisphenol A results in decreased expression of MFSD2A mRNA CTD PMID:26063408 more ... bisphenol A decreases expression ISO RGD:1606200 6480464 bisphenol A results in decreased expression of MFSD2A mRNA CTD PMID:31715268 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MFSD2A mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1615020 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol F affects expression ISO RGD:1615020 6480464 bisphenol F affects the expression of MFSD2A mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MFSD2A mRNA CTD PMID:32479839 buspirone increases expression EXP 6480464 Buspirone results in increased expression of MFSD2A mRNA CTD PMID:24136188 butanal increases expression ISO RGD:1606200 6480464 butyraldehyde results in increased expression of MFSD2A mRNA CTD PMID:26079696 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of MFSD2A mRNA CTD PMID:19167457 calcitriol increases expression ISO RGD:1606200 6480464 Calcitriol results in increased expression of MFSD2A mRNA CTD PMID:16002434 , PMID:26485663 carbon nanotube affects expression ISO RGD:1615020 6480464 Nanotubes, Carbon affects the expression of MFSD2A mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1615020 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chlordecone increases expression ISO RGD:1615020 6480464 Chlordecone results in increased expression of MFSD2A mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1615020 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFSD2 mRNA CTD PMID:20938992 chrysene increases expression ISO RGD:1615020 6480464 chrysene results in increased expression of MFSD2A mRNA CTD PMID:26377693 ciguatoxin CTX1B affects expression ISO RGD:1615020 6480464 Ciguatoxins affects the expression of MFSD2 mRNA CTD PMID:18353800 clobetasol increases expression ISO RGD:1615020 6480464 Clobetasol results in increased expression of MFSD2A mRNA CTD PMID:27462272 copper(II) sulfate increases expression ISO RGD:1606200 6480464 Copper Sulfate results in increased expression of MFSD2A mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of MFSD2A mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1606200 6480464 Cyclosporine results in decreased expression of MFSD2A mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1606200 6480464 Cyclosporine results in increased expression of MFSD2A mRNA CTD PMID:27989131 dextran sulfate increases expression ISO RGD:1615020 6480464 Dextran Sulfate results in increased expression of MFSD2A mRNA CTD PMID:23894361 dextran sulfate decreases expression ISO RGD:1615020 6480464 Dextran Sulfate results in decreased expression of MFSD2A mRNA CTD PMID:35093514 dibenzo[a,l]pyrene decreases expression ISO RGD:1615020 6480464 dibenzo(a, l)pyrene results in decreased expression of MFSD2A mRNA CTD PMID:25908611 dibutyl phthalate increases expression ISO RGD:1615020 6480464 Dibutyl Phthalate results in increased expression of MFSD2 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1615020 6480464 Dichloroacetic Acid results in increased expression of MFSD2A mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:1615020 6480464 Diclofenac results in increased expression of MFSD2A mRNA CTD PMID:35537566 dioxygen decreases expression ISO RGD:1606200 6480464 Oxygen deficiency results in decreased expression of MFSD2A mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:1615020 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFSD2A mRNA CTD PMID:30529165 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of MFSD2A mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1615020 6480464 epoxiconazole results in decreased expression of MFSD2A mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1615020 6480464 [Ethanol co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MFSD2A protein CTD PMID:33516661 ethanol affects expression ISO RGD:1615020 6480464 Ethanol affects the expression of MFSD2A mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1615020 6480464 Ethanol results in increased expression of MFSD2A mRNA CTD PMID:30319688 fenofibrate decreases expression ISO RGD:1606200 6480464 Fenofibrate results in decreased expression of MFSD2A mRNA CTD PMID:25572481 folic acid multiple interactions ISO RGD:1615020 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFSD2 mRNA CTD PMID:20938992 folic acid multiple interactions ISO RGD:1606200 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of MFSD2 mRNA CTD PMID:24657277 fulvestrant increases methylation ISO RGD:1606200 6480464 Fulvestrant results in increased methylation of MFSD2A gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MFSD2A mRNA CTD PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of MFSD2A mRNA CTD PMID:24915197 GW 4064 decreases expression ISO RGD:1615020 6480464 GW 4064 results in decreased expression of MFSD2A mRNA CTD PMID:26655953 ketamine increases expression EXP 6480464 Ketamine results in increased expression of MFSD2A mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:1615020 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFSD2 mRNA CTD PMID:20938992 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of MFSD2A mRNA CTD PMID:24136188 lipopolysaccharide increases expression ISO RGD:1606200 6480464 Lipopolysaccharides results in increased expression of MFSD2A mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1606200 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MFSD2A mRNA CTD PMID:35811015 lysophosphatidylcholine increases transport ISO RGD:1606200 6480464 MFSD2A results in increased transport of Lysophosphatidylcholines CTD PMID:26005865 melphalan increases expression ISO RGD:1606200 6480464 Melphalan results in increased expression of MFSD2A mRNA CTD PMID:22363485 metformin affects expression EXP 6480464 Metformin affects the expression of MFSD2A mRNA CTD PMID:31324951 methotrexate multiple interactions ISO RGD:1606200 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of MFSD2 mRNA CTD PMID:24657277 methotrexate increases expression ISO RGD:1606200 6480464 Methotrexate results in increased expression of MFSD2 mRNA CTD PMID:24657277 methylisothiazolinone increases expression ISO RGD:1606200 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MFSD2A mRNA CTD PMID:31629900 N-nitrosodiethylamine multiple interactions ISO RGD:1615020 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of MFSD2A mRNA CTD PMID:24535843 N-Nitrosopyrrolidine decreases expression ISO RGD:1606200 6480464 N-Nitrosopyrrolidine results in decreased expression of MFSD2A mRNA CTD PMID:32234424 naphthalene increases expression ISO RGD:1615020 6480464 naphthalene results in increased expression of MFSD2A mRNA CTD PMID:18978301 nickel atom increases expression ISO RGD:1606200 6480464 Nickel results in increased expression of MFSD2A mRNA CTD PMID:23195993 , PMID:25583101 O-methyleugenol decreases expression ISO RGD:1606200 6480464 methyleugenol results in decreased expression of MFSD2A mRNA CTD PMID:32234424 obeticholic acid increases expression ISO RGD:1606200 6480464 obeticholic acid results in increased expression of MFSD2A mRNA CTD PMID:27939613 ozone multiple interactions ISO RGD:1615020 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MFSD2A mRNA, [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of MFSD2 mRNA CTD PMID:25658374 , PMID:34911549 paracetamol affects expression ISO RGD:1615020 6480464 Acetaminophen affects the expression of MFSD2A mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1606200 6480464 Acetaminophen results in decreased expression of MFSD2A mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of MFSD2A mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:1606200 6480464 pentanal results in increased expression of MFSD2A mRNA CTD PMID:26079696 perfluorononanoic acid decreases expression ISO RGD:1606200 6480464 perfluoro-n-nonanoic acid results in decreased expression of MFSD2A mRNA CTD PMID:32588087 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of MFSD2A mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:1615020 6480464 Phenobarbital results in increased expression of MFSD2A mRNA CTD PMID:19270015 phenobarbital decreases expression ISO RGD:1615020 6480464 Phenobarbital results in decreased expression of MFSD2A mRNA CTD PMID:19270015 , PMID:19482888 phenobarbital multiple interactions ISO RGD:1615020 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of MFSD2A mRNA CTD PMID:24535843 pirinixic acid increases expression ISO RGD:1615020 6480464 pirinixic acid results in increased expression of MFSD2A mRNA CTD PMID:18301758 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1615020 6480464 Pregnenolone Carbonitrile results in increased expression of MFSD2A mRNA CTD PMID:28903501 rac-lactic acid increases expression ISO RGD:1606200 6480464 Lactic Acid results in increased expression of MFSD2A mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of MFSD2A mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1606200 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of MFSD2A mRNA CTD PMID:33725128 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1606200 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MFSD2A mRNA CTD PMID:35811015 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of MFSD2A mRNA CTD PMID:15967596 sodium arsenite decreases expression ISO RGD:1606200 6480464 sodium arsenite results in decreased expression of MFSD2A mRNA CTD PMID:29301061 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of MFSD2A mRNA CTD PMID:25993096 succimer multiple interactions ISO RGD:1615020 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFSD2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1606200 6480464 Sunitinib results in decreased expression of MFSD2A mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:1615020 6480464 Testosterone deficiency results in decreased expression of MFSD2A mRNA CTD PMID:33848595 tetrachloromethane decreases expression ISO RGD:1615020 6480464 Carbon Tetrachloride results in decreased expression of MFSD2A mRNA CTD PMID:27339419 tetrachloromethane affects expression ISO RGD:1615020 6480464 Carbon Tetrachloride affects the expression of MFSD2A mRNA CTD PMID:31919559 tetraphene increases expression ISO RGD:1615020 6480464 benz(a)anthracene results in increased expression of MFSD2A mRNA CTD PMID:26377693 thapsigargin decreases expression ISO RGD:1606200 6480464 Thapsigargin results in decreased expression of MFSD2A mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MFSD2 mRNA, Thioacetamide results in decreased expression of MFSD2A mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:1615020 6480464 titanium dioxide results in increased expression of MFSD2 mRNA, titanium dioxide results in increased expression of MFSD2A mRNA CTD PMID:23409001 , PMID:27760801 titanium dioxide affects expression ISO RGD:1615020 6480464 titanium dioxide affects the expression of MFSD2A mRNA CTD PMID:23557971 trichloroethene increases expression ISO RGD:1615020 6480464 Trichloroethylene results in increased expression of MFSD2A mRNA CTD PMID:25549359 trimellitic anhydride increases expression ISO RGD:1615020 6480464 trimellitic anhydride results in increased expression of MFSD2 mRNA CTD PMID:19042947 Triptolide decreases expression ISO RGD:1615020 6480464 triptolide results in decreased expression of MFSD2A mRNA CTD PMID:32835833 troglitazone decreases expression ISO RGD:1606200 6480464 troglitazone results in decreased expression of MFSD2 mRNA CTD PMID:25572481 trovafloxacin increases expression ISO RGD:1615020 6480464 trovafloxacin results in increased expression of MFSD2A mRNA CTD PMID:35537566 tunicamycin decreases expression ISO RGD:1606200 6480464 Tunicamycin results in decreased expression of MFSD2A mRNA CTD PMID:22378314 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of MFSD2A mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1615020 6480464 Valproic Acid affects the expression of MFSD2A mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1606200 6480464 Valproic Acid results in increased expression of MFSD2A mRNA CTD PMID:25716160 , PMID:29154799 vancomycin increases expression ISO RGD:1615020 6480464 Vancomycin results in increased expression of MFSD2A mRNA CTD PMID:18930951